Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | PRCP | P42785 | 4/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | EBP | Q15125 | 1/20 | 0.37 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11682900 | 0.92 | OPRD1 (0.48) | OPRD1KCNH2PRCPSIGMAR1OPRM1 | |
| SCHEMBL11686121 | 0.88 | TSHR (0.42) | OPRD1KCNH2PRCPSIGMAR1 | |
| SCHEMBL11687660 | 0.80 | PRCP (0.49) | OPRD1KCNH2PRCPSIGMAR1OPRM1 | |
| SCHEMBL11683068 | 0.79 | ALDH1A1 (0.40) | OPRD1KCNH2PRCP | |
| SCHEMBL11867362 | 0.77 | PRCP (0.50) | OPRD1KCNH2PRCPSIGMAR1 | |
| SCHEMBL11849331 | 0.75 | PRCP (0.51) | OPRD1PRCPSIGMAR1OPRM1OPRK1 | |
| SCHEMBL11859455 | 0.74 | DRD2 (0.61) | SIGMAR1SLC18A3 | |
| SCHEMBL11882106 | 0.73 | OPRD1 (0.44) | OPRD1KCNH2PRCPSIGMAR1OPRM1 | |
| SCHEMBL11686154 | 0.72 | PRCP (0.43) | OPRD1KCNH2PRCPSIGMAR1 | |
| SCHEMBL11424749 | 0.72 | TMEM97 (0.37) | OPRD1KCNH2PRCPSIGMAR1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4024263-A | ANALGESIC, ANTICONVULSANT, ANTIDEPRESSANT | AMERICAN HOECHST CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |